Cannabis Global (Cannabis Global) Equity-to-Asset : 0.22 (As of May. 2022)

View and export this data going back to 2008. Start your Free Trial

What is Cannabis Global Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Cannabis Global's Total Stockholders Equity for the quarter that ended in May. 2022 was $3.21 Mil. Cannabis Global's Total Assets for the quarter that ended in May. 2022 was $14.91 Mil. Therefore, Cannabis Global's Equity to Asset Ratio for the quarter that ended in May. 2022 was 0.22.

The historical rank and industry rank for Cannabis Global's Equity-to-Asset or its related term are showing as below:

CBGL's Equity-to-Asset is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.58
* Ranked among companies with meaningful Equity-to-Asset only.

Cannabis Global Equity-to-Asset Historical Data

The historical data trend for Cannabis Global's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabis Global Equity-to-Asset Chart

Cannabis Global Annual Data

Trend

Aug12

Aug13

Aug14

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Equity-to-Asset

Get a 7-Day Free Trial

-17.80

-27.00

0.28

-0.62

-0.20

Cannabis Global Quarterly Data
	Aug17	Nov17	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22
Equity-to-Asset	Get a 7-Day Free Trial															-0.03	-0.20	0.05	0.23	0.22

Competitive Comparison of Cannabis Global's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Global's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannabis Global's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Global's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Cannabis Global's Equity-to-Asset falls into.

Cannabis Global Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Cannabis Global's Equity to Asset Ratio for the fiscal year that ended in Aug. 2021 is calculated as

Equity to Asset (A: Aug. 2021 )	=	Total Stockholders Equity	/	Total Assets
	=	-2.212	/	11.339
	=	-0.20

Cannabis Global's Equity to Asset Ratio for the quarter that ended in May. 2022 is calculated as

Equity to Asset (Q: May. 2022 )	=	Total Stockholders Equity	/	Total Assets
	=	3.213	/	14.909
	=	0.22

Cannabis Global (OTCPK:CBGL) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Cannabis Global Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Cannabis Global's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannabis Global (Cannabis Global) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabis Global Inc (OTCPK:CBGL) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

520 S. Grand Avenue, Suite 320, Los Angeles, CA, USA, 90071

Website

https://www.cannabisglobalinc.com

Cannabis Global manufactures and distributes various cannabis products via its majority ownership of Natural Plant Extract, Inc is developing the Ethos Comply Bag, and generally conducts research and development in the areas of hemp, cannabis and consumer food goods. The company also have an active research and development program primarily focused on creating and commercializing engineered technologies that deliver hemp extracts and cannabinoids to the human body. Its product includes cannabis flower packaged in various weights, cannabis Pre-rolls, cannabis edible products.

Executives

Jim L. Riley	director	C/O CANNABIS GLOBAL INC., 520 S GRAND AVENUE, SUITE 320, LOS ANGELES CA 90071
Ghs Investments, Llc	10 percent owner	0830 SOUTH EASTERN AVENUE, #124-376, LAS VEGAS NV 89123
Hymers Iii R. Leslie	director, 10 percent owner	520 S GRAND AVENUE, STE 320, LOS ANGELES CA 90071
Arman Tabatabaei	director, officer: CEO, CFO	520 SOUTH GRAND AVENUE, SUITE 320, LOS ANGELES CA 90071
Lauderdale Holdings, Llc	director, 10 percent owner, officer: CEO/President/CFO	1919 NW 19 STREET, FT LAUDERDALE FL 33311
Harmel S Rayat	10 percent owner	700 - 688 WEST HASTINGS STREET, VANCOUVER A1 V6B 1P1
David A Gamache	director, officer: SECRETARY/TREASURER/CFO	3905 NATIONAL DRIVE, SUITE 110, BURTONSVILLE MD 20866
Meetesh V Patel	director, officer: PRESIDENT/CEO	8775 CENTRE PARK DRIVE, # 210, COLUMBIA MD 21045
Pattiann Hiranandani	director	3905 NATIONAL DRIVE, BURTONSVILLE MD 20866